---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-374323"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2026-08-28T20:05:15+00:00"
generated_at: "2026-08-28T20:08:56.259196+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Outset Medical General Counsel John Brottem to depart Sept 11, 2026

## Summary
- John Brottem, General Counsel, will leave Outset Medical effective September 11, 2026.
- Departure to pursue other professional opportunities; no dispute or disagreement cited.
- No successor or interim General Counsel has been named as of filing date.

## SEC filing metadata
- accession: 0001193125-26-374323
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2026-08-28T20:05:15+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000119312526374323/0001193125-26-374323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000119312526374323/om-20260827.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-374323
- JSON: https://secwatch.observer/filing/0001193125-26-374323.json
- Plain text: https://secwatch.observer/filing/0001193125-26-374323.txt

## Key facts
- Executive change
  John Brottem departed as General Counsel at Outset Medical, Inc..
  - Action: depart
  - Role: General Counsel
  source text: On August 27, 2026, John Brottem informed Outset Medical, Inc. (the “Company”) of his decision to depart from the Company and his role as General Counsel, effective September 11, 2026, to pursue other professional opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000119312526374323/0001193125-26-374323-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.